Related Experiment Videos
MR demonstration of intraosseous beta-2-microglobulin amyloidosis
T Kokubo1, Y Takatori, I Okutsu
1Department of Radiology, University of Tokyo, Japan.
Journal of Computer Assisted Tomography
|November 1, 1990
Abstract:
We present a case of intraosseous beta-2-microglobulin amyloidosis of a patient receiving long-term hemodialysis. Magnetic resonance imaging clearly demonstrated intraosseous amyloid deposits as hypointense masses in the femoral head.
Insights
We describe a rare case of beta-2-microglobulin amyloidosis affecting bone in a patient undergoing long-term hemodialysis. Imaging revealed amyloid deposits in the femoral head, offering insights into this complication of kidney disease.
Area of Science:
- Nephrology
- Rheumatology
- Radiology
Background:
- Beta-2-microglobulin amyloidosis is a known complication in patients with end-stage renal disease requiring long-term hemodialysis.
- Intraosseous involvement, while less common, can lead to significant morbidity.
Observation:
- A case is presented of a patient with long-term hemodialysis who developed intraosseous beta-2-microglobulin amyloidosis.
- Magnetic resonance imaging (MRI) was utilized to visualize the affected area.
Findings:
- MRI demonstrated intraosseous amyloid deposits within the femoral head.
- These deposits appeared as characteristic hypointense masses on the imaging.
Implications:
- This case highlights the importance of considering beta-2-microglobulin amyloidosis in the differential diagnosis of bone lesions in dialysis patients.
- Advanced imaging like MRI is crucial for accurate diagnosis and characterization of intraosseous amyloidosis.
- Understanding the radiological features can aid in clinical management and patient care.